The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone
January 2014
in “Human Reproduction”
TLDR Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.
The 2014 study with 447 women investigated the prevalence of polycystic ovary syndrome (PCOS) using the Rotterdam criteria and proposed revised criteria including anti-Müllerian hormone (AMH). The prevalence of PCOS was 16.6% with the Rotterdam criteria, but when using AMH or antral follicle count (AFC) as markers, the prevalence decreased to 6.3% and 8.5%, respectively. Women with PCOS had higher BMI, obesity rates, hirsutism, and LH to FSH ratios, and significantly higher median serum AMH levels. The study concluded that AMH is a useful marker for PCOS and suggested that the Rotterdam criteria be revised to include age adjustments and validated AMH threshold levels to prevent overdiagnosis, especially in younger women. The study also noted potential selection bias and excluded hormonal contraceptive users.
View this study on academic.oup.com →
Cited in this study
research Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
Women with PCOS should be screened for heart disease risk and manage their health to prevent it.
research The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.
research Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.
research Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.
Related
research The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone
Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.